Stratagene Shares Continue Slide | GenomeWeb

Shares in Stratagene fell 15 percent for the week ended Tuesday. The firm's shares led decliners in the BCW Index for the third week in a row. Since the beginning of May, Stratagene's shares have lost nearly half their value, though the reasons for the drop remain unclear (see related article).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.